Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/21/24 18:00 | 11/19/24 | ANTX | Health | Drug | Pharmaceutical Preparations | Readnour Robin Shane | CA | D | 1 | P.m | 213 | 1.07 | 0 | 200 | 64 | 515 | I | |||||||||||||||
11/20/24 16:11 | 11/18/24 | ANTX | Health | Drug | Pharmaceutical Preparations | Zakrzewski Joseph S | CA | D | 1 | P.m | 25 | 1.00 | 0 | 25 | 5 | 529 | D | |||||||||||||||
11/18/24 20:51 | 11/18/24 | ANTX | Health | Drug | Pharmaceutical Preparations | Easom Eric | CA | DO | CEO | 1 | P | 50 | 0.9994 | 0 | 50 | 4 | 1,361 | I | ||||||||||||||
8/14/24 20:24 | 8/14/24 | ANTX | Health | Drug | Pharmaceutical Preparations | Leonard Braden Michael | IN | T | 1 | P | 1,560 | 1.04 | 0 | 1,500 | 35 | 5,749 | I | |||||||||||||||
8/22/23 17:01 | 8/18/23 | ANTX | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | T | 1 | P | 16,000 | 9.00 | 0 | 1,778 | 47 | 5,551 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |